Testing the Universality of Fragmentation Functions

Using fragmentation functions for charged pions, charged kaons, and (anti)protons recently extracted from experimental data of e^+e^- annihilation at the Z-boson resonance and at centre-of-mass energy root(s) = 29 GeV, we perform a global study of inclusive charged-hadron production in p anti-p, gamma p, and gamma gamma collisions at next-to-leading order in the parton model of quantum chromodynamics. Comparisons of our results with p anti-p data from CERN S p anti-p S and the Fermilab Tevatron, gamma p data from DESY HERA, and gamma gamma data from CERN LEP2 allow us to test the universality of the fragmentation functions predicted by the factorization theorem. Furthermore, we perform comparisons with (e^+e^-)-annihilation data from LEP2 so as to test the scaling violations predicted by the Altarelli-Parisi evolution equations.Comment: 35 pages (Latex), 15 figures (Postscript

An Exploratory Study on Determinants of Regular Group Indoor Cycling Participation in Black and White Adults

This study investigated factors influencing regular group indoor cycling (GIC) participation in a sample of Black (71%) and White (29%) adults. Seventeen regular GIC participants (≥1 day/week for ≥3 consecutive months) completed surveys that examined motivations for GIC participation. Treatment Self-Regulation Questionnaire (TSRQ), Preference for and Tolerance of Intensity of Exercise Questionnaire (PRETIE-Q), and open-ended survey questions were used. TSRQ showed autonomous motivation was significantly higher than controlled (p \u3c.001) and amotivation (p \u3c .001), with no significant difference between controlled and amotivation (p = .08). There was no significant interaction between motivation and race. There were no significant differences between race groups for PRETIE-Q. Five themes emerged as reasons for GIC participation: music, physical health, social support, studio atmosphere, and enjoyment/fun. Racial differences surfaced in the themes. More research is needed to understand the role of cultural relevance as it relates to exercise motivation and regular exercise participation. This could inform strategies for promoting regular exercise in various populations

Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma

Craniopharyngiomas are locally aggressive tumors which typically are focused in the sellar and suprasellar region near a number of critical neural and vascular structures mediating endocrinologic, behavioral, and visual functions. The present study aims to summarize and compare the published literature regarding morbidity resulting from treatment of craniopharyngioma. We performed a comprehensive search of the published English language literature to identify studies publishing outcome data of patients undergoing surgery for craniopharyngioma. Comparisons of the rates of endocrine, vascular, neurological, and visual complications were performed using Pearson’s chi-squared test, and covariates of interest were fitted into a multivariate logistic regression model. In our data set, 540 patients underwent surgical resection of their tumor. 138 patients received biopsy alone followed by some form of radiotherapy. Mean overall follow-up for all patients in these studies was 54 ± 1.8 months. The overall rate of new endocrinopathy for all patients undergoing surgical resection of their mass was 37% (95% CI = 33–41). Patients receiving GTR had over 2.5 times the rate of developing at least one endocrinopathy compared to patients receiving STR alone or STR + XRT (52 vs. 19 vs. 20%, χ2P < 0.00001). On multivariate analysis, GTR conferred a significant increase in the risk of endocrinopathy compared to STR + XRT (OR = 3.45, 95% CI = 2.05–5.81, P < 0.00001), after controlling for study size and the presence of significant hypothalamic involvement. There was a statistical trend towards worse visual outcomes in patients receiving XRT after STR compared to GTR or STR alone (GTR = 3.5% vs. STR 2.1% vs. STR + XRT 6.4%, P = 0.11). Given the difficulty in obtaining class 1 data regarding the treatment of this tumor, this study can serve as an estimate of expected outcomes for these patients, and guide decision making until these data are available

Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Craniopharyngiomas are locally aggressive tumors which typically are focused in the sellar and suprasellar region near a number of critical neural and vascular structures mediating endocrinologic, behavioral, and visual functions. The present study aims to summarize and compare the published literature regarding morbidity resulting from treatment of craniopharyngioma. We performed a comprehensive search of the published English language literature to identify studies publishing outcome data of patients undergoing surgery for craniopharyngioma. Comparisons of the rates of endocrine, vascular, neurological, and visual complications were performed using Pearson's chi-squared test, and covariates of interest were fitted into a multivariate logistic regression model. In our data set, 540 patients underwent surgical resection of their tumor. 138 patients received biopsy alone followed by some form of radiotherapy. Mean overall follow-up for all patients in these studies was 54 ± 1.8 months. The overall rate of new endocrinopathy for all patients undergoing surgical resection of their mass was 37% (95% CI = 33-41). Patients receiving GTR had over 2.5 times the rate of developing at least one endocrinopathy compared to patients receiving STR alone or STR + XRT (52 vs. 19 vs. 20%, χ(2) P &lt; 0.00001). On multivariate analysis, GTR conferred a significant increase in the risk of endocrinopathy compared to STR + XRT (OR = 3.45, 95% CI = 2.05-5.81, P &lt; 0.00001), after controlling for study size and the presence of significant hypothalamic involvement. There was a statistical trend towards worse visual outcomes in patients receiving XRT after STR compared to GTR or STR alone (GTR = 3.5% vs. STR 2.1% vs. STR + XRT 6.4%, P = 0.11). Given the difficulty in obtaining class 1 data regarding the treatment of this tumor, this study can serve as an estimate of expected outcomes for these patients, and guide decision making until these data are available